Skip to main content

Charles River’s Memphis cell therapy facility gains entry into European Union market

“Receiving the GMP certification allows [our] Memphis [facility] to manufacture commercial-grade cell therapy drug products for distribution in Europe.”
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.